Innovative Medical disclosed its performance forecast, expecting a net loss attributable to the parent company of 48 million to 62 million yuan in the first half of 2026, compared with a loss of 11.3613 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 51 million to 65 million yuan, compared with a loss of 12.8841 million yuan in the same period last year. Basic earnings per share are between negative 0.11 yuan and negative 0.14 yuan. The company stated that the decline in performance was mainly due to factors such as the adjustment of medical insurance policies in the location of Jianhua Hospital and the price reduction from centralized procurement of drugs and consumables.
Innovative Medical Management Co LtdExpects widened net loss due to medical insurance policy adjustment and centralized procurement price cuts.